Literature DB >> 8165071

Noninvasive monitoring of oxygenation in infants and children: practical considerations and areas of concern.

C F Poets1, D P Southall.   

Abstract

OBJECTIVE: To review the technical principles of transcutaneous PO2 (tcPO2) monitors and pulse oximeters and to discuss methodological and practical issues related to the use of these devices in infants and children.
DESIGN: Literature review and summary of personal experience.
RESULTS: tcPO2 measurements are influenced by skin thickness, sensor temperature, amount of contact gel used, and state of peripheral perfusion. The average in vivo response time to a rapid decrease in PaO2 is approximately 16 seconds. Sensitivity to both hypoxemia (PaO2 < 50 mm Hg) and hyperoxemia (PaO2 > 80 to 100 mm Hg) is approximately 85%. Pulse oximeters require careful sensor placement (to avoid optical shunts) and adequate pulse pressures (> 20 mm Hg). They are prone to movement artifact. There are considerable differences in bias and precision between different brands, resulting, for example, in quite different upper alarm limits required to detect hyperoxemia reliably. The normal range of oxygen saturation measured by pulse oximetry, measured with one brand of pulse oximeter (Nellcor) during regular breathing, is 95% to 100% in preterm infants and 97% to 100% in full-term infants and children.
CONCLUSIONS: Because both devices have their specific shortfalls, they should ideally be used in combination, particularly in critically ill preterm neonates. Where this is not feasible or necessary, clinicians must be aware of the limitations of the device they are using.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165071

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation.

Authors:  W Tin; D W Milligan; P Pennefather; E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

2.  Validation of oxygen saturation monitoring in neonates.

Authors:  Shyang-Yun Pamela K Shiao; Ching-Nan Ou
Journal:  Am J Crit Care       Date:  2007-03       Impact factor: 2.228

Review 3.  Should pulse oximetry be used to screen for congenital heart disease?

Authors:  Pekka Valmari
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

Review 4.  Diagnostic issues in pediatric obstructive sleep apnea.

Authors:  Hiren Muzumdar; Raanan Arens
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

5.  A new system to record reliable pulse oximetry data from the Nellcor N-200 and its applications in studies of variability in infant oxygenation.

Authors:  D Sprague; M S Richardson; J W Baish; J S Kemp
Journal:  J Clin Monit       Date:  1996-01

6.  Arterial oxygen saturation in healthy term neonates.

Authors:  C F Poets; V A Stebbens; J A Lang; L M O'Brien; A W Boon; D P Southall
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

Review 7.  Intermittent Hypoxemia in Preterm Infants.

Authors:  Juliann M Di Fiore; Peter M MacFarlane; Richard J Martin
Journal:  Clin Perinatol       Date:  2019-06-15       Impact factor: 3.430

8.  Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial.

Authors:  F Sandri; G Ancora; A Lanzoni; P Tagliabue; M Colnaghi; M L Ventura; M Rinaldi; I Mondello; P Gancia; G P Salvioli; M Orzalesi; F Mosca
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

9.  Arterial oxygen saturation profiles in healthy preterm infants.

Authors:  A Ng; N Subhedar; R A Primhak; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

10.  The reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants.

Authors:  J D Reich; B Connolly; G Bradley; S Littman; W Koeppel; P Lewycky; M Liske
Journal:  Pediatr Cardiol       Date:  2008-09       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.